Leo Pharma appoints new medical director

Leo Pharma has announced the appointment of Dr Sathish Kolli as its new medical director for the UK and Ireland.

Dr Kolli most recently served as the acting global medical affairs director at the Neuroscience Centre of Excellence at GlaxoSmithKline, while he has also previously been employed by AstraZeneca, Schwarz Pharma and the NHS.

He will bring extensive healthcare sector and pharmaceutical industry experience to his new role, which will see him tasked with enhancing the company's patient-centred strategic model.

Geraldine Murphy, managing director for Leo Pharma in the UK and Ireland, said: "I am confident that his leadership, together with extensive clinical knowledge and pharmaceutical expertise gained across several different therapy areas, will prove to be invaluable to our dermatology and thrombosis teams."

This comes after the company announced the appointment of Mike Williams as its dermatology director and Barbara Reilly as its thrombosis division leader earlier this year.